PRODUCTS
Program | Therapeutic Area | Development Stage | Milestones | ||
|
|||||
Ruzurgi | Neurology |
Available via Named Patient Supply
Pending
|
TGA registration September 2021. Reimbursement Q2 2022 |
||
K-Citra | Urology |
K-Citra Registered
|
Available since December 2021 | ||
ORS003 | Hospital Critical Care |
Transfer of manufacturer
|
MA transfer estimated February 2022 | ||
ORS004 | Oncology |
In development
|
To be advised | ||
ORS005 | Antimycobacterial |
Final Regulatory preparation for submission
|
Registration estimated 2023 |